Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-01-30 11:06 am Purchase | 13G | SPRUCE BIOSCIENCES INC SPRB | Rosalind Advisors Inc. | 2,322,000 5.67% | 2,322,000 (New Position) | View |
| 2023-11-28 4:53 pm Sale | 13D | DELCATH SYS INC DCTH | Rosalind Advisors Inc. | 2,410,524 9.9% | -102,227 (-4.07%) | View |
| 2023-08-28 1:46 pm Purchase | 13G | MYOMO INC MYO | Rosalind Advisors Inc. | 7,333,334 9.8% | 6,780,044 (+1225.41%) | View |
| 2023-07-27 6:09 pm Purchase | 13G | OPTINOSE INC OPTN | Rosalind Advisors Inc. | 6,435,000 5.8% | 6,435,000 (New Position) | View |
| 2023-06-07 5:33 pm Purchase | 13G | INSPIREMD INC NSPR | Rosalind Advisors Inc. | 8,988,318 9.9% | 8,988,318 (New Position) | View |
| 2023-02-15 3:19 pm Purchase | 13G | SIENTRA INC SIEN | Rosalind Advisors Inc. | 509,274 5% | 509,274 (New Position) | View |
| 2023-02-15 1:16 pm Purchase | 13G | TREVI THERAPEUTICS INC TRVI | Rosalind Advisors Inc. | 2,499,993 4.2% | 314,329 (+14.38%) | View |
| 2023-02-13 5:53 pm Unchanged | 13G | CELLECTAR BIOSCIENCES INC CLRB | Rosalind Advisors Inc. | 2,158,272 9.97% | 0 (Unchanged) | View |
| 2022-12-21 12:37 pm Purchase | 13G | MEDIWOUND LTD MDWD | Rosalind Advisors Inc. | 444,326 6.1% | 444,326 (New Position) | View |
| 2022-12-21 12:17 pm Purchase | 13D | DELCATH SYS INC DCTH | Rosalind Advisors Inc. | 2,512,751 9.9% | 692,042 (+38.01%) | View |
| 2022-11-02 8:03 pm Sale | 13G | CELLECTAR BIOSCIENCES INC CLRB | Rosalind Advisors Inc. | 2,158,272 9.97% | -3,894,010 (-64.34%) | View |
| 2022-07-21 3:52 pm Purchase | 13D | DELCATH SYS INC DCTH | Rosalind Advisors Inc. | 1,820,709 9.9% | 566,751 (+45.20%) | View |
| 2022-07-06 4:34 pm Purchase | 13G | GUIDED THERAPEUTICS GTHP | Rosalind Advisors Inc. | 2,338,740 8.3% | 2,338,740 (New Position) | View |
| 2022-03-09 5:09 pm Purchase | 13G | TREVI THERAPEUTICS INC TRVI | Rosalind Advisors Inc. | 2,185,664 8.5% | 2,185,664 (New Position) | View |
| 2022-03-09 4:45 pm Unchanged | 13D | DELCATH SYS INC DCTH | Rosalind Advisors Inc. | 1,253,958 9.9% | 0 (Unchanged) | View |
| 2022-02-14 5:09 pm Unchanged | 13D | DELCATH SYS INC DCTH | Rosalind Advisors Inc. | 1,253,958 9.9% | 0 (Unchanged) | View |
| 2022-02-14 4:12 pm Sale | 13G | PHASEBIO PHARMACEUTICALS INC C PHAS | Rosalind Advisors Inc. | 707,467 1.5% | -1,900,390 (-72.87%) | View |
| 2022-02-14 3:15 pm Sale | 13G | PLX PHARMA INC PLXP | Rosalind Advisors Inc. | 0 0% | -970,425 (Position Closed) | View |
| 2022-02-11 5:14 pm Purchase | 13G | GALERA THERAPEUTICS INC GRTX | Rosalind Advisors Inc. | 1,543,783 5.8% | 1,543,783 (New Position) | View |
| 2022-01-21 3:49 pm Purchase | 13G | CELLECTAR BIOSCIENCES INC CLRB | Rosalind Advisors Inc. | 6,052,282 9.97% | 2,845,122 (+88.71%) | View |